Studies how patients take part in atopic dermatitis research
Looks at how many people finish atopic dermatitis trials and who leaves early.
Key facts
- Who runs it
- Power Life Sciences Inc.
- Where
- San Francisco, United StatesSee the site
- Trial code
- Registry title
- Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
- Status
- Not yet recruiting
- People taking part
- 500 people, planned
- Started
- Jan 2025
- Expected to end
- Jan 2027
- Type of study
- Observational
- Record updated
- 12 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a confirmed diagnosis of atopic dermatitis who can give written consent. It studies how many patients finish or leave atopic dermatitis trials.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Confirmed diagnosis of atopic dermatitis; no stage or severity is stated
Main reasons for not taking part
- Enrolled in another research study
- Pregnant, breastfeeding or expecting to conceive during the study
- Cannot give written informed consent
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Ability to understand and the willingness to sign a written informed consent document
- Participant must be 18 years of age or older
- Confirmed diagnosis of atopic dermatitis
Who cannot take part
- Enrolled in another research study
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
- Inability to provide written informed consent
Where in United States
- Power Life SciencesSan Francisco, United StatesContact: Michael B GillNot yet recruiting
About the trial
What the trial wants to find out
Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
Read full original descriptionShow less
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Understanding Patient Engagement Trends in Atopic Dermatitis Clinical Research
- Plain-language title
- Studies how patients take part in atopic dermatitis researchGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 12 February 2024